Antineoplastic And Immunomodulating Agents - Drug Delivery - Roactemra 2025. The Subject Of Performance Are Continuous Supplies According To Annex 1 Purchase Contracts - Price Offer, To The Extent And In Accordance With The Tender Conditions Are Supplies Of The Medicinal Product Tocilizumab - L04ac07.
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
